by Endotracheal tubes are medical devices inserted through the mouth or nose to establish an airway in patients undergoing surgery or suffering from respiratory diseases and disorders. They enable emergency ventilation of the lungs during anesthesia, intensive care, and critical care. The growing prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma has boosted the demand for endotracheal tubes across hospitals and healthcare facilities.
The global endotracheal tube market is estimated to be valued at US$ 920 Mn in 2023 and is expected to exhibit a CAGR of 9.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Increasing Demand for Single-Use Endotracheal Tubes
Single-use endotracheal tubes are witnessing massive demand owing to the high risk of infection associated with reusable tubes. Hospitals and ambulatory surgical centers are shifting their focus toward disposable endotracheal tubes to prevent the transmission of diseases. This widespread adoption of single-use endotracheal tubes is one of the major trends contributing to the growth of the market. Their features such as high biocompatibility and negligible risk of cross-contamination drive their demand significantly.
SWOT Analysis
Strength: Endotracheal tubes provide a non-invasive way for ventilating and oxygenating patients. These tubes ensure an open airway and allow access for suctioning secretions.
Weakness: Presence of an endotracheal tube can irritate the trachea and cause complications like ventilator-associated pneumonia. Improper insertion or prolonged intubation can also damage the tracheal walls.
Opportunity: Rising incidence of respiratory diseases, increasing number of ICU admissions, and surge in geriatric population prone to respiratory failure drive the demand for endotracheal tubes. Growth opportunities exist in emerging markets of Asia Pacific and Latin America.
Threats: Alternative non-invasive ventilation techniques can replace endotracheal intubation in certain cases. Stringent regulatory requirements add to the production costs.
Key Takeaways
The Global Endotracheal Tube Market Size is expected to witness high growth. The global endotracheal tube market is estimated to be valued at US$ 920 Mn in 2023 and is expected to exhibit a CAGR of 9.0% over the forecast period 2023 to 2030.
Regional analysis: North America currently dominates the market owing to high healthcare spending and rising prevalence of respiratory diseases in the US and Canada. However, Asia Pacific is expected to register fastest growth during the forecast period supported by expanding healthcare infrastructure, increasing medical tourism, and growing geriatric population in China and India.
Key players related content comprises Key players operating in the Endotracheal Tube market are Medtronic Plc, Teleflex Inc., ConvaTec Inc., Smiths Medical, Neurovision Medical Products, Intersurgical Inc., Royax, Novo Klinik-Service GmbH, Avanos Medical, Inc., Bactiguard, and N8 Medical LLC. Endotracheal tubes manufactured by these companies are used extensively in critical care units, emergency rooms, and operating rooms for ventilation support to COVID patients and those undergoing surgeries among others. The key players are focusing on new product launches, partnerships, and geographic expansions to strengthen their market presence.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
